The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of systemic chemotherapy with S-1 plus oxaliplatin followed by surgery in patients with cT3-T4a and/or node-positive advanced adenocarcinoma of the esophagogastric junction: Primary endpoint results of the ESOX trial.
 
Yu Imamura
No Relationships to Disclose
 
Keisho Chin
No Relationships to Disclose
 
Takahiro Tsushima
Honoraria - Bayer; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Yasuhiro Tsubosa
No Relationships to Disclose
 
Hiroki Hara
Honoraria - Bayer; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Merck Serono; MSD; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
Consulting or Advisory Role - Lilly; MSD; Ono Pharmaceutical
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Dainippon Sumitomo Pharma (Inst); Eisai (Inst); Incyte (Inst); LSK BioPharma (Inst); Merck Serono (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Taiho Pharmaceutical (Inst)
 
Takashi Fukuda
No Relationships to Disclose
 
Motoo Nomura
Research Funding - Canon Medical System
 
Shigeru Tsunoda
No Relationships to Disclose
 
Takashi Ogata
No Relationships to Disclose
 
Tsutomu Hayashi
No Relationships to Disclose
 
Yoshihiro Nabeya
No Relationships to Disclose
 
Keiko Minashi
Research Funding - Astellas Pharma (Inst); Daiichi Sankyo (Inst); MSD (Inst); Ono Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Hidekazu Kuramochi
No Relationships to Disclose
 
Mie Hamano
No Relationships to Disclose
 
Ayako Doi
No Relationships to Disclose
 
Shinya Mikami
No Relationships to Disclose
 
Shinji Mine
No Relationships to Disclose
 
Naoki Ishizuka
No Relationships to Disclose
 
Takashi Ichimura
No Relationships to Disclose